Tenaya Therapeutics, Inc.
TNYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $46 | $95 | $38 |
| Short-Term Investments | $57 | $59 | $91 | $213 |
| Receivables | $0 | $0 | $2 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $7 | $5 | $4 |
| Total Curr. Assets | $67 | $112 | $194 | $255 |
| Property Plant & Equip (Net) | $48 | $53 | $63 | $55 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $18 | $1 |
| Tax Assets | $0 | $0 | $0 | $2 |
| Other NC Assets | $5 | $6 | $5 | $4 |
| Total NC Assets | $53 | $59 | $85 | $61 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $120 | $171 | $279 | $317 |
| Liabilities | – | – | – | – |
| Payables | $5 | $6 | $10 | $11 |
| Short-Term Debt | $3 | $4 | $4 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $13 | $11 | $9 |
| Total Curr. Liab. | $16 | $23 | $24 | $22 |
| LT Debt | $11 | $8 | $11 | $14 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $2 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $11 | $8 | $11 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $11 | $12 | $15 | $14 |
| Total Liabilities | $27 | $31 | $36 | $38 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$514 | -$403 | -$279 | -$156 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $607 | $543 | $523 | $434 |
| Total Equity | $93 | $139 | $243 | $279 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $120 | $171 | $279 | $317 |
| Net Debt | $9 | -$33 | -$80 | -$22 |